Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cystic Fibrosis Drugs market report explains the definition, types, applications, major countries, and major players of the Cystic Fibrosis Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
United Medical
Neovii Biotech
Proteostasis Therapeutics
Venus Remedies
Novartis
Insmed
Boehringer Ingelheim
Corbus Pharmaceuticals
PharmaSwiss
F Hoffmann-La Roche
Novo Nordisk
Actavis
Gilead Sciences
Johnson & Johnson
Pharmaxis
Anthera Pharmaceuticals
PTC Therapeutics
Arcturus Therapeutics
Abbott
Vertex Pharmaceuticals
Chiesi Farmaceutici
Genzyme
Merck Sharp & Dohme
By Type:
Oral
Injection
By End-User:
Hospitals
Clinics
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Cystic Fibrosis Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Cystic Fibrosis Drugs Outlook to 2028- Original Forecasts
-
2.2 Cystic Fibrosis Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Cystic Fibrosis Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Cystic Fibrosis Drugs Market- Recent Developments
-
6.1 Cystic Fibrosis Drugs Market News and Developments
-
6.2 Cystic Fibrosis Drugs Market Deals Landscape
7 Cystic Fibrosis Drugs Raw Materials and Cost Structure Analysis
-
7.1 Cystic Fibrosis Drugs Key Raw Materials
-
7.2 Cystic Fibrosis Drugs Price Trend of Key Raw Materials
-
7.3 Cystic Fibrosis Drugs Key Suppliers of Raw Materials
-
7.4 Cystic Fibrosis Drugs Market Concentration Rate of Raw Materials
-
7.5 Cystic Fibrosis Drugs Cost Structure Analysis
-
7.5.1 Cystic Fibrosis Drugs Raw Materials Analysis
-
7.5.2 Cystic Fibrosis Drugs Labor Cost Analysis
-
7.5.3 Cystic Fibrosis Drugs Manufacturing Expenses Analysis
8 Global Cystic Fibrosis Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Cystic Fibrosis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Cystic Fibrosis Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Cystic Fibrosis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Cystic Fibrosis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Cystic Fibrosis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Cystic Fibrosis Drugs Market Analysis and Outlook till 2022
-
10.1 Global Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.2.2 Canada Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.2.3 Mexico Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.2 UK Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.3 Spain Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.4 Belgium Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.5 France Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.6 Italy Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.7 Denmark Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.8 Finland Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.9 Norway Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.10 Sweden Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.11 Poland Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.12 Russia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.3.13 Turkey Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.2 Japan Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.3 India Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.4 South Korea Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.8 Thailand Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.9 Singapore Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.11 Philippines Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.2 Colombia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.3 Chile Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.4 Argentina Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.6 Peru Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6.3 Oman Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6.4 Qatar Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.7.2 South Africa Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.7.3 Egypt Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.7.4 Algeria Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Cystic Fibrosis Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Cystic Fibrosis Drugs Consumption (2017-2022)
11 Global Cystic Fibrosis Drugs Competitive Analysis
-
11.1 United Medical
-
11.1.1 United Medical Company Details
-
11.1.2 United Medical Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 United Medical Cystic Fibrosis Drugs Main Business and Markets Served
-
11.1.4 United Medical Cystic Fibrosis Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Neovii Biotech
-
11.2.1 Neovii Biotech Company Details
-
11.2.2 Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Neovii Biotech Cystic Fibrosis Drugs Main Business and Markets Served
-
11.2.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Proteostasis Therapeutics
-
11.3.1 Proteostasis Therapeutics Company Details
-
11.3.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
11.3.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Venus Remedies
-
11.4.1 Venus Remedies Company Details
-
11.4.2 Venus Remedies Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Venus Remedies Cystic Fibrosis Drugs Main Business and Markets Served
-
11.4.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Cystic Fibrosis Drugs Main Business and Markets Served
-
11.5.4 Novartis Cystic Fibrosis Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Insmed
-
11.6.1 Insmed Company Details
-
11.6.2 Insmed Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Insmed Cystic Fibrosis Drugs Main Business and Markets Served
-
11.6.4 Insmed Cystic Fibrosis Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Boehringer Ingelheim
-
11.7.1 Boehringer Ingelheim Company Details
-
11.7.2 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Boehringer Ingelheim Cystic Fibrosis Drugs Main Business and Markets Served
-
11.7.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Corbus Pharmaceuticals
-
11.8.1 Corbus Pharmaceuticals Company Details
-
11.8.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
11.8.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 PharmaSwiss
-
11.9.1 PharmaSwiss Company Details
-
11.9.2 PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 PharmaSwiss Cystic Fibrosis Drugs Main Business and Markets Served
-
11.9.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 F Hoffmann-La Roche
-
11.10.1 F Hoffmann-La Roche Company Details
-
11.10.2 F Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 F Hoffmann-La Roche Cystic Fibrosis Drugs Main Business and Markets Served
-
11.10.4 F Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novo Nordisk
-
11.11.1 Novo Nordisk Company Details
-
11.11.2 Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novo Nordisk Cystic Fibrosis Drugs Main Business and Markets Served
-
11.11.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Actavis
-
11.12.1 Actavis Company Details
-
11.12.2 Actavis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Actavis Cystic Fibrosis Drugs Main Business and Markets Served
-
11.12.4 Actavis Cystic Fibrosis Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Gilead Sciences
-
11.13.1 Gilead Sciences Company Details
-
11.13.2 Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Gilead Sciences Cystic Fibrosis Drugs Main Business and Markets Served
-
11.13.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Johnson & Johnson
-
11.14.1 Johnson & Johnson Company Details
-
11.14.2 Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Johnson & Johnson Cystic Fibrosis Drugs Main Business and Markets Served
-
11.14.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Pharmaxis
-
11.15.1 Pharmaxis Company Details
-
11.15.2 Pharmaxis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Pharmaxis Cystic Fibrosis Drugs Main Business and Markets Served
-
11.15.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Anthera Pharmaceuticals
-
11.16.1 Anthera Pharmaceuticals Company Details
-
11.16.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
11.16.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 PTC Therapeutics
-
11.17.1 PTC Therapeutics Company Details
-
11.17.2 PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 PTC Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
11.17.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Arcturus Therapeutics
-
11.18.1 Arcturus Therapeutics Company Details
-
11.18.2 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Arcturus Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
11.18.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Abbott
-
11.19.1 Abbott Company Details
-
11.19.2 Abbott Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Abbott Cystic Fibrosis Drugs Main Business and Markets Served
-
11.19.4 Abbott Cystic Fibrosis Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Vertex Pharmaceuticals
-
11.20.1 Vertex Pharmaceuticals Company Details
-
11.20.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
11.20.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Chiesi Farmaceutici
-
11.21.1 Chiesi Farmaceutici Company Details
-
11.21.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Main Business and Markets Served
-
11.21.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Genzyme
-
11.22.1 Genzyme Company Details
-
11.22.2 Genzyme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Genzyme Cystic Fibrosis Drugs Main Business and Markets Served
-
11.22.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Merck Sharp & Dohme
-
11.23.1 Merck Sharp & Dohme Company Details
-
11.23.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Main Business and Markets Served
-
11.23.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
-
11.23.5 Recent Research and Development Strategies
12 Global Cystic Fibrosis Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Cystic Fibrosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Cystic Fibrosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Cystic Fibrosis Drugs Market Analysis and Outlook to 2028
-
13.1 Global Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Cystic Fibrosis Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Cystic Fibrosis Drugs
-
Figure of Cystic Fibrosis Drugs Picture
-
Table Global Cystic Fibrosis Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Cystic Fibrosis Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Table North America Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure United States Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure Germany Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure China Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure Brazil Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Cystic Fibrosis Drugs Consumption by Country (2017-2022)
-
Figure Australia Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Cystic Fibrosis Drugs Consumption and Growth Rate (2017-2022)
-
Table United Medical Company Details
-
Table United Medical Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table United Medical Cystic Fibrosis Drugs Main Business and Markets Served
-
Table United Medical Cystic Fibrosis Drugs Product Portfolio
-
Table Neovii Biotech Company Details
-
Table Neovii Biotech Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neovii Biotech Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
-
Table Proteostasis Therapeutics Company Details
-
Table Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Proteostasis Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
Table Venus Remedies Company Details
-
Table Venus Remedies Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Venus Remedies Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Venus Remedies Cystic Fibrosis Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Novartis Cystic Fibrosis Drugs Product Portfolio
-
Table Insmed Company Details
-
Table Insmed Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insmed Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Insmed Cystic Fibrosis Drugs Product Portfolio
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
-
Table Corbus Pharmaceuticals Company Details
-
Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
Table PharmaSwiss Company Details
-
Table PharmaSwiss Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmaSwiss Cystic Fibrosis Drugs Main Business and Markets Served
-
Table PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Cystic Fibrosis Drugs Main Business and Markets Served
-
Table F Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
-
Table Actavis Company Details
-
Table Actavis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Actavis Cystic Fibrosis Drugs Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
-
Table Pharmaxis Company Details
-
Table Pharmaxis Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmaxis Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Pharmaxis Cystic Fibrosis Drugs Product Portfolio
-
Table Anthera Pharmaceuticals Company Details
-
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
Table PTC Therapeutics Company Details
-
Table PTC Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table PTC Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
Table PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
Table Arcturus Therapeutics Company Details
-
Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arcturus Therapeutics Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Abbott Cystic Fibrosis Drugs Product Portfolio
-
Table Vertex Pharmaceuticals Company Details
-
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
-
Table Chiesi Farmaceutici Company Details
-
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
-
Table Genzyme Company Details
-
Table Genzyme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Genzyme Cystic Fibrosis Drugs Product Portfolio
-
Table Merck Sharp & Dohme Company Details
-
Table Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp & Dohme Cystic Fibrosis Drugs Main Business and Markets Served
-
Table Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Cystic Fibrosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Cystic Fibrosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
